Randomized trial · people
VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In one small human trial, inhaled aviptadil added to standard care was well tolerated and tied to shorter hospital stays and better lung CT scores in COVID-19 patients.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 80
- Published
- 2025
- Journal
- Med Princ Pract
What they tested
The team tested whether inhaled aviptadil, added to standard care, sped recovery in adults hospitalized with COVID-19.
How the study was done
A randomized, double-blind, placebo-controlled trial in 80 hospitalized adults with COVID-19 at 9 centers. Patients were split evenly between inhaled aviptadil and placebo (a dummy treatment), both on top of standard care, and the main measure was time to discharge within 30 days.

What they found
Average time to discharge was 7.8 days with aviptadil and 10 days with placebo (p = 0.049). On the modified Borg scale, a rating of how breathless patients felt, scores did not differ by group on day 3 but were lower with aviptadil on day 7 (p = 0.033). Lung damage scores on CT scans were similar on day 1, and improvement by day 28 was greater with aviptadil (p = 0.028). Deaths were 5.1% with aviptadil and 12.2% with placebo, and no patient dropped out because of side effects.
What it doesn’t show
This was a small trial of 80 patients, and the gap in time to discharge fell just under the usual cutoff for statistical significance. It covered only adults hospitalized with COVID-19 and followed them for about a month, so it shows nothing about other conditions or longer-term effects.
The paper
Esendagli et al. Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19. Med Princ Pract. 2025.
The compound
More studies on VIP
- VIP fragment VIP10-28 boosted, not blocked, skin vessel wideningClinical trial · people · 2005
- VIP: peak flow rose 26 l/min in severe asthma, less than salbutamolClinical trial · people · 1986
- VIP: tear levels rose after laser eye surgery, peaking at 1 weekObservational study · people · 2023
- Every study on VIP
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.